Research progress on substitution of <i>in vivo</i> method(s) by <i>in vitro</i> method(s) for human vaccine potency assays-Reference-Cited by-同舟云学术

Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays

Published:2023-03-06 Issue:1 Volume:22 Page:270-277
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Zhang Xuanxuan¹,Wu Xing¹,He Qian¹,Wang Junzhi¹,Mao Qunying¹,Liang Zhenglun¹,Xu Miao¹

Affiliation:

1. Institute of Biological Products, Division of Hepatitis and Enterovirus Vaccines, National Institutes for Food and Drug Control, Beijing, China

Funder

CAMS Innovation Fund for Medical Sciences

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2023.2178421

Reference76 articles.

1. Vaccines Licensed for Use in the United States [Internet]. Washington D.C: FDA [2022 November 30] Available from: https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states

2. ChPC. Pharmacopoeia of the People’s Republic of China (VolIII). Beijing: China Medical Science Press; 2020.

3. EDQM. . European Pharmacopoeia. 10.0th ed. Strasbourgh France: European Department for the Quality of Medicines. 2019.

4. Vaccine Potency Assays

5. Principles of vaccine potency assays

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel envelope protein time-resolved fluoroimmunoassay as an alternative in vitro potency assay for quality control of inactivated Japanese encephalitis virus vaccine;Heliyon;2024-06

2. Potency, immunogenicity, and efficacy of rabies vaccine: In vitro and in vivo approach;Immunity, Inflammation and Disease;2024-02

3. Applications of Biotechnology in Pharmaceutical Product Analysis;Interdisciplinary Biotechnological Advances;2024

4. CRISPR-Cas9 KO Cell Line Generation and Development of a Cell-Based Potency Assay for rAAV-FKRP Gene Therapy;Cells;2023-10-12

5. Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccines;Vaccine;2023-08